FDA Inspection 750198 — Wiegmann, Dr Thomas

Wiegmann, Dr Thomas — FEI 3000839560

The FDA completed an inspection of Wiegmann, Dr Thomas on Oct 14, 2011 in Kansas City, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Oct 14, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Kansas City, MO (United States)

Additional Details

Clinical Investigator (CI)